BCRX – biocryst pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
H.C. Wainwright Lifts PT on BioCryst Pharmaceuticals (BCRX) to $32 From $30 [Yahoo! Finance]
Does The Market Misread BioCryst Pharmaceuticals After DCF Upside And Low Sales Multiple In 2025? [Yahoo! Finance]
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target raised by analysts at HC Wainwright from $30.00 to $32.00. They now have a "buy" rating on the stock.
BioCryst Announces FDA Approval of ORLADEYO® (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with HAE Aged 2 to <12 Years [Yahoo! Finance]
BioCryst Announces FDA Approval of ORLADEYO® (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with HAE Aged 2 to <12 Years
Form 4 BIOCRYST PHARMACEUTICALS For: Dec 19 Filed by: Stonehouse Jon P
Form 4 BIOCRYST PHARMACEUTICALS For: Dec 19 Filed by: Barnes Alane P
Form 4 BIOCRYST PHARMACEUTICALS For: Dec 19 Filed by: Gayer Charles K
Form 144 BIOCRYST PHARMACEUTICALS Filed by: Barnes Alane P
Form 4 BIOCRYST PHARMACEUTICALS For: Dec 18 Filed by: Stonehouse Jon P
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.